Meng, Delong
Zhao, Xin
Yang, Yu Chi http://orcid.org/0000-0001-8318-1174
Navickas, Albertas
Helland, Ciara
Goodarzi, Hani
Singh, Mallika
Bandyopadhyay, Sourav
Funding for this research was provided by:
Foundation for the National Institutes of Health (U01CA224081)
Article History
Received: 7 October 2022
Revised: 30 April 2023
Accepted: 18 May 2023
First Online: 1 June 2023
Competing interests
: YCY, CH, and MS are employees and stockholders of Revolution Medicines. SB has consulting and research funding relationships with Pfizer, Ideaya Biosciences and Revolution Medicines.